Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 468.06
   
  • Change Today:
    $8.65
  • 52 Week High: $516.74
  • 52 Week Low: $396.64
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 366,567
  • Market Cap: $120,263m
  • RiskGrade: 164

Latest ShareCast News

US open: S&P 500, Nasdaq at record highs on strength in Morgan Stanley, Biotech

By Alexander Bueso

Date: Wednesday 19 Jul 2017

(ShareCast News) - The S&P 500 and Nasdaq Composite pushed further into record territory on the back of better-than-expected results from Morgan Stanley, with tech shares pacing the advance despite weak numbers out of Big Blue thanks to a run-up in biotech shares.

Concert Pharma shares rocket 81% higher following cystic fibrosis drug deal

By Conor Coyle

Date: Monday 06 Mar 2017

(ShareCast News) - US healthcare firm Concert Pharmaceuticals' share price shot up more than 80% on Monday after the company announced a deal to sell its cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals for $250m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 468.06
Change Today $ 8.65
% Change 1.88 %
52 Week High $516.74
52 Week Low $396.64
Volume 366,567
Shares Issued 256.94m
Market Cap $120,263m
RiskGrade 164

What The Brokers Say

Strong Buy 7
Buy 10
Neutral 12
Sell 1
Strong Sell 1
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 08-Jul-2025

Time Volume / Share Price
12:56 100 @ $468.06
12:56 100 @ $468.43
12:56 100 @ $468.43
12:56 100 @ $468.43
12:56 100 @ $468.43

Top of Page